Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

142 results

Filters applied: . Clear all
Page 1
A naïve comparison to assess the success of ultra-short implants.
Barman S, Singh N, Pant VA, Aamir M, Biswas S. Barman S, et al. Among authors: biswas s. Natl J Maxillofac Surg. 2024 Jan-Apr;15(1):121-130. doi: 10.4103/njms.njms_82_22. Epub 2024 Mar 19. Natl J Maxillofac Surg. 2024. PMID: 38690245 Free PMC article.
CONCLUSIONS: Within the limitations, it was thus concluded that ultra-short implants may be considered as a viable treatment option for vertically insufficient mandibular ridge. Further, long-term randomized controlled trials are required to establish the evidence....
CONCLUSIONS: Within the limitations, it was thus concluded that ultra-short implants may be considered as a viable treatment option for vert …
Double Trouble: Exploring Bilateral Acetabular Fractures in a Trauma Patient.
Smith E, Deal AC, Biswas S. Smith E, et al. Among authors: biswas s. Cureus. 2024 Mar 25;16(3):e56889. doi: 10.7759/cureus.56889. eCollection 2024 Mar. Cureus. 2024. PMID: 38659564 Free PMC article.
Bilateral acetabular fractures, though rare, pose significant challenges in both diagnosis and management due to their association with high-energy trauma and the potential for long-term disability. This case report presents the clinical course of a 27-year-old female who …
Bilateral acetabular fractures, though rare, pose significant challenges in both diagnosis and management due to their association with high …
Synergistic Al-Al Dual-Atomic Site for Efficient Artificial Nitrogen Fixation.
Biswas S, Zhou J, Chen XL, Chi C, Pan YA, Cui P, Li J, Liu C, Xia XH. Biswas S, et al. Angew Chem Int Ed Engl. 2024 Apr 11:e202405493. doi: 10.1002/anie.202405493. Online ahead of print. Angew Chem Int Ed Engl. 2024. PMID: 38604975
This Al(2)NC catalyst exhibits a high Faradaic efficiency of 16.560.3 % with a yield rate of 29.221.2 mug h(-1) mg(cat) (-1). The dual atomic Al(2)NC catalyst shows long-term repeatable, and stable NRR performance. This work presents an insight into the identification of s …
This Al(2)NC catalyst exhibits a high Faradaic efficiency of 16.560.3 % with a yield rate of 29.221.2 mug h(-1) mg(cat) (-1). The dual atomi …
The presence and burden of cognitive issues: discordance between the perception of neurologists and people living with multiple sclerosis.
Penner IK, Heras VL, Jones E, Hetherington S, Karu H, Chetlangia R, Biswas S, Castro PD, Lines C. Penner IK, et al. Among authors: biswas s. Eur J Neurol. 2024 Mar 18:e16234. doi: 10.1111/ene.16234. Online ahead of print. Eur J Neurol. 2024. PMID: 38500270 Free article.
Neurologists reported only 27% of plwMS as having 'difficulty concentrating' and 15% of plwMS as having 'short-/long-term memory problems'. Neurologists reported cognitive or mood symptoms as 'not experienced' by a higher percentage of participants with relapsing-remitting …
Neurologists reported only 27% of plwMS as having 'difficulty concentrating' and 15% of plwMS as having 'short-/long-term memory prob …
Long-Term Follow-Up of Abatacept, Post-Transplantation Cyclophosphamide, and Sirolimus-Based Haploidentical Transplantation in Younger Patients with Nonmalignant Diseases.
Jaiswal SR, Agarwal M, Bhagawati G, Das BC, Baligar P, Garg M, Biswas S, Chakrabarti S. Jaiswal SR, et al. Among authors: biswas s. Transplant Cell Ther. 2024 Mar 13:S2666-6367(24)00260-4. doi: 10.1016/j.jtct.2024.03.010. Online ahead of print. Transplant Cell Ther. 2024. PMID: 38490295
Building on promising results from pilot studies in which abatacept was combined with post-transplantation cyclophosphamide (PTCy) and sirolimus (AbaCyS) in younger NMD patients undergoing haplo-HCT, we present the long-term outcomes of this protocol. On the back of unifor …
Building on promising results from pilot studies in which abatacept was combined with post-transplantation cyclophosphamide (PTCy) and sirol …
An integrative ayurvedic approach in management of breast abscess - A case report.
Jaivarshaa Gv P, Dasar D, Biswas S, Kumar A. Jaivarshaa Gv P, et al. Among authors: biswas s. J Ayurveda Integr Med. 2024 Jan-Feb;15(1):100890. doi: 10.1016/j.jaim.2024.100890. Epub 2024 Feb 21. J Ayurveda Integr Med. 2024. PMID: 38387146 Free PMC article.
Breast inflammation known as mastitis has the potential to develop into a breastabscess in the future. The term "stana roga," refers to breast disorders and describes breast abscesses, is mentioned in the ancient works Sushruta Samhita, Madhava Nidana, and Bhavaprakasha. . …
Breast inflammation known as mastitis has the potential to develop into a breastabscess in the future. The term "stana roga," refers …
Sex-specific genetic risks for adverse outcomes after coronary revascularization procedures.
Nurkkala JM, Aittokallio J; FinnGen; Kauko A, Niiranen T. Nurkkala JM, et al. Interdiscip Cardiovasc Thorac Surg. 2024 Jan 2;38(1):ivae006. doi: 10.1093/icvts/ivae006. Interdiscip Cardiovasc Thorac Surg. 2024. PMID: 38216540 Free PMC article.
We calculated PRSs for all individuals and used Cox models with interaction term to examine the sex-specific associations between the PRSs and adverse outcomes after revascularization. ...
We calculated PRSs for all individuals and used Cox models with interaction term to examine the sex-specific associations between the …
The everolimus eluting Synergy MegatronTM drug-eluting stent platform: Early outcomes from the European Synergy MegatronTM Implanters' Registry.
De Silva K, Li Kam Wa ME, Wells T, Mozid A, Ladwiniec A, Hynes BG, Kotecha A, Ratib K, Biswas S, Amabile N, Deharo P, McEntagart M, Spratt JC, Digne F, Hogg M, Mailey JA, Walsh SJ, Kalra SS. De Silva K, et al. Among authors: biswas s. Catheter Cardiovasc Interv. 2023 Dec;102(7):1222-1228. doi: 10.1002/ccd.30902. Epub 2023 Nov 10. Catheter Cardiovasc Interv. 2023. PMID: 37948428 Free PMC article.
BACKGROUND: The Synergy Megatron(TM) is an everolimus-drug eluting stent that may offer advantages in the treatment of aorto-ostial disease and large proximal vessels. AIMS: To report the short- to medium-term clinical outcomes from the European Synergy Megatron(TM) Implan …
BACKGROUND: The Synergy Megatron(TM) is an everolimus-drug eluting stent that may offer advantages in the treatment of aorto-ostial disease …
Beyond uniformity: Exploring the heterogeneous and dynamic nature of the microtubule lattice.
Romeiro Motta M, Biswas S, Schaedel L. Romeiro Motta M, et al. Among authors: biswas s. Eur J Cell Biol. 2023 Dec;102(4):151370. doi: 10.1016/j.ejcb.2023.151370. Epub 2023 Oct 29. Eur J Cell Biol. 2023. PMID: 37922811 Free article. Review.
Instrumental to these discoveries were in vitro microtubule reconstitution assays, in which microtubules are grown from the minimal components required for their dynamics. In this review, we propose a shift from the term "lattice self-repair" to "lattice dynamics", since t …
Instrumental to these discoveries were in vitro microtubule reconstitution assays, in which microtubules are grown from the minimal componen …
Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After Medication Escalation: The RADIANCE Clinical Trial Program.
Azizi M, Sharp ASP, Fisher NDL, Weber MA, Lobo MD, Daemen J, Lurz P, Mahfoud F, Schmieder RE, Basile J, Bloch MJ, Saxena M, Wang Y, Sanghvi K, Jenkins JS, Devireddy C, Rader F, Gosse P, Claude L, Augustin DA, McClure CK, Kirtane AJ; RADIANCE Investigators. Azizi M, et al. Circulation. 2024 Mar 5;149(10):747-759. doi: 10.1161/CIRCULATIONAHA.123.066941. Epub 2023 Oct 26. Circulation. 2024. PMID: 37883784 Clinical Trial.
BACKGROUND: The randomized, sham-controlled RADIANCE-HTN (A Study of the Recor Medical Paradise System in Clinical Hypertension) SOLO, RADIANCE-HTN TRIO, and RADIANCE II (A Study of the Recor Medical Paradise System in Stage II Hypertension) trials independently met their primary …
BACKGROUND: The randomized, sham-controlled RADIANCE-HTN (A Study of the Recor Medical Paradise System in Clinical Hypertension) SOLO, RADIA …
142 results